25 XP   0   0   10

Embecta Corp
Buy, Hold or Sell?

Let's analyse Embecta together

PenkeI guess you are interested in Embecta Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Embecta Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Embecta Corp

I send you an email if I find something interesting about Embecta Corp.

Quick analysis of Embecta (30 sec.)










What can you expect buying and holding a share of Embecta? (30 sec.)

How much money do you get?

How much money do you get?
$0.75
When do you have the money?
1 year
How often do you get paid?
46.2%

What is your share worth?

Current worth
$-13.77
Expected worth in 1 year
$-27.52
How sure are you?
38.5%

+ What do you gain per year?

Total Gains per Share
$-13.01
Return On Investment
-125.1%

For what price can you sell your share?

Current Price per Share
$10.40
Expected price per share
$9.925 - $13.60
How sure are you?
50%

1. Valuation of Embecta (5 min.)




Live pricePrice per Share (EOD)

$10.40

Intrinsic Value Per Share

$-72.75 - $-89.35

Total Value Per Share

$-86.52 - $-103.12

2. Growth of Embecta (5 min.)




Is Embecta growing?

Current yearPrevious yearGrowGrow %
How rich?-$793.5m-$885.6m$73.8m9.1%

How much money is Embecta making?

Current yearPrevious yearGrowGrow %
Making money$13.8m$45m-$31.2m-225.9%
Net Profit Margin4.9%18.4%--

How much money comes from the company's main activities?

3. Financial Health of Embecta (5 min.)




4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  

What can you expect buying and holding a share of Embecta? (5 min.)

Welcome investor! Embecta's management wants to use your money to grow the business. In return you get a share of Embecta.

What can you expect buying and holding a share of Embecta?

First you should know what it really means to hold a share of Embecta. And how you can make/lose money.

Speculation

The Price per Share of Embecta is $10.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Embecta.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Embecta, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-13.77. Based on the TTM, the Book Value Change Per Share is $-3.44 per quarter. Based on the YOY, the Book Value Change Per Share is $-2.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.19 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Embecta.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.353.4%0.242.3%0.545.2%0.938.9%0.938.9%
Usd Book Value Change Per Share0.504.8%-3.44-33.1%-2.39-23.0%-1.06-10.2%-1.06-10.2%
Usd Dividend Per Share0.151.4%0.191.8%0.040.4%0.070.7%0.070.7%
Usd Total Gains Per Share0.656.3%-3.25-31.3%-2.36-22.7%-0.99-9.5%-0.99-9.5%
Usd Price Per Share18.93-20.93-28.18-15.11-15.11-
Price to Earnings Ratio13.57-24.76-2,578.23-800.92-800.92-
Price-to-Total Gains Ratio29.05--36.88--6.35--21.61--21.61-
Price to Book Ratio-1.37--1.48--436.09--134.64--134.64-
Price-to-Total Gains Ratio29.05--36.88--6.35--21.61--21.61-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share10.4
Number of shares96
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.190.07
Usd Book Value Change Per Share-3.44-1.06
Usd Total Gains Per Share-3.25-0.99
Gains per Quarter (96 shares)-312.17-95.06
Gains per Year (96 shares)-1,248.69-380.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
172-1320-125926-407-390
2143-2641-250853-813-770
3215-3961-375779-1220-1150
4287-5281-5006106-1627-1530
5358-6602-6255132-2033-1910
6430-7922-7504159-2440-2290
7502-9243-8753185-2847-2670
8573-10563-10002212-3254-3050
9645-11883-11251238-3660-3430
10717-13204-12500265-4067-3810

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%12.01.00.092.3%12.01.00.092.3%12.01.00.092.3%
Book Value Change Per Share2.02.00.050.0%5.05.02.041.7%5.05.03.038.5%5.05.03.038.5%5.05.03.038.5%
Dividend per Share4.00.00.0100.0%6.00.06.050.0%6.00.07.046.2%6.00.07.046.2%6.00.07.046.2%
Total Gains per Share2.02.00.050.0%5.05.02.041.7%5.05.03.038.5%5.05.03.038.5%5.05.03.038.5%

Fundamentals of Embecta

About Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Fundamental data was last updated by Penke on 2024-04-09 18:05:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Embecta Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Embecta earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Embecta to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 7.2% means that $0.07 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Embecta Corp:

  • The MRQ is 7.2%. The company is making a profit. +1
  • The TTM is 4.9%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.2%TTM4.9%+2.3%
TTM4.9%YOY18.4%-13.4%
TTM4.9%5Y20.8%-15.8%
5Y20.8%10Y20.8%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2%6.2%+1.0%
TTM4.9%6.2%-1.3%
YOY18.4%8.0%+10.4%
5Y20.8%7.3%+13.5%
10Y20.8%6.8%+14.0%
1.1.2. Return on Assets

Shows how efficient Embecta is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Embecta to the Medical Instruments & Supplies industry mean.
  • 1.7% Return on Assets means that Embecta generated $0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Embecta Corp:

  • The MRQ is 1.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 1.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.7%TTM1.1%+0.5%
TTM1.1%YOY4.6%-3.5%
TTM1.1%5Y3.7%-2.6%
5Y3.7%10Y3.7%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7%1.3%+0.4%
TTM1.1%1.4%-0.3%
YOY4.6%1.9%+2.7%
5Y3.7%2.2%+1.5%
10Y3.7%2.0%+1.7%
1.1.3. Return on Equity

Shows how efficient Embecta is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Embecta to the Medical Instruments & Supplies industry mean.
  • 0.0% Return on Equity means Embecta generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Embecta Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y2.6%-2.6%
5Y2.6%10Y2.6%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6%-2.6%
TTM-2.8%-2.8%
YOY-3.7%-3.7%
5Y2.6%3.9%-1.3%
10Y2.6%3.9%-1.3%

1.2. Operating Efficiency of Embecta Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Embecta is operating .

  • Measures how much profit Embecta makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Embecta to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 15.1% means the company generated $0.15  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Embecta Corp:

  • The MRQ is 15.1%. The company is operating efficient. +1
  • The TTM is 16.0%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ15.1%TTM16.0%-0.9%
TTM16.0%YOY33.3%-17.2%
TTM16.0%5Y31.2%-15.1%
5Y31.2%10Y31.2%0.0%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ15.1%7.9%+7.2%
TTM16.0%7.6%+8.4%
YOY33.3%10.9%+22.4%
5Y31.2%10.1%+21.1%
10Y31.2%10.5%+20.7%
1.2.2. Operating Ratio

Measures how efficient Embecta is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.84 means that the operating costs are $0.84 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Embecta Corp:

  • The MRQ is 0.836. The company is less efficient in keeping operating costs low.
  • The TTM is 0.839. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.836TTM0.839-0.003
TTM0.839YOY0.773+0.066
TTM0.8395Y0.720+0.119
5Y0.72010Y0.7200.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8361.153-0.317
TTM0.8391.168-0.329
YOY0.7731.105-0.332
5Y0.7201.097-0.377
10Y0.7201.056-0.336

1.3. Liquidity of Embecta Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Embecta is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 2.20 means the company has $2.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Embecta Corp:

  • The MRQ is 2.203. The company is able to pay all its short-term debts. +1
  • The TTM is 2.119. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.203TTM2.119+0.084
TTM2.119YOY2.333-0.213
TTM2.1195Y1.632+0.488
5Y1.63210Y1.6320.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2032.302-0.099
TTM2.1192.333-0.214
YOY2.3332.588-0.255
5Y1.6322.627-0.995
10Y1.6322.623-0.991
1.3.2. Quick Ratio

Measures if Embecta is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Embecta to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 1.55 means the company can pay off $1.55 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Embecta Corp:

  • The MRQ is 1.547. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.408. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.547TTM1.408+0.139
TTM1.408YOY1.606-0.198
TTM1.4085Y1.055+0.352
5Y1.05510Y1.0550.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5471.098+0.449
TTM1.4081.127+0.281
YOY1.6061.306+0.300
5Y1.0551.430-0.375
10Y1.0551.533-0.478

1.4. Solvency of Embecta Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Embecta assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Embecta to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 1.65 means that Embecta assets are financed with 165.2% credit (debt) and the remaining percentage (100% - 165.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Embecta Corp:

  • The MRQ is 1.652. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.664. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.652TTM1.664-0.012
TTM1.664YOY1.872-0.208
TTM1.6645Y1.126+0.537
5Y1.12610Y1.1260.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6520.357+1.295
TTM1.6640.360+1.304
YOY1.8720.353+1.519
5Y1.1260.365+0.761
10Y1.1260.371+0.755
1.4.2. Debt to Equity Ratio

Measures if Embecta is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Embecta to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Embecta Corp:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.052-0.052
5Y0.05210Y0.0520.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.541-0.541
TTM-0.561-0.561
YOY-0.551-0.551
5Y0.0520.653-0.601
10Y0.0520.669-0.617

2. Market Valuation of Embecta Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Embecta generates.

  • Above 15 is considered overpriced but always compare Embecta to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 13.57 means the investor is paying $13.57 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Embecta Corp:

  • The EOD is 7.455. Based on the earnings, the company is cheap. +2
  • The MRQ is 13.569. Based on the earnings, the company is underpriced. +1
  • The TTM is 24.761. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD7.455MRQ13.569-6.114
MRQ13.569TTM24.761-11.192
TTM24.761YOY2,578.234-2,553.472
TTM24.7615Y800.922-776.160
5Y800.92210Y800.9220.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD7.45514.408-6.953
MRQ13.56915.934-2.365
TTM24.76116.376+8.385
YOY2,578.23422.147+2,556.087
5Y800.92220.830+780.092
10Y800.92225.069+775.853
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Embecta Corp:

  • The EOD is -9.484. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -17.262. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -11.872. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.484MRQ-17.262+7.778
MRQ-17.262TTM-11.872-5.391
TTM-11.872YOY1,637.378-1,649.250
TTM-11.8725Y500.156-512.028
5Y500.15610Y500.1560.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-9.4849.511-18.995
MRQ-17.2629.241-26.503
TTM-11.8720.922-12.794
YOY1,637.3783.453+1,633.925
5Y500.1565.897+494.259
10Y500.156-0.177+500.333
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Embecta is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of -1.37 means the investor is paying $-1.37 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Embecta Corp:

  • The EOD is -0.755. Based on the equity, the company is expensive. -2
  • The MRQ is -1.375. Based on the equity, the company is expensive. -2
  • The TTM is -1.484. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.755MRQ-1.375+0.620
MRQ-1.375TTM-1.484+0.109
TTM-1.484YOY-436.085+434.602
TTM-1.4845Y-134.637+133.153
5Y-134.63710Y-134.6370.000
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD-0.7552.448-3.203
MRQ-1.3752.753-4.128
TTM-1.4842.691-4.175
YOY-436.0853.294-439.379
5Y-134.6373.563-138.200
10Y-134.6374.227-138.864
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Embecta Corp.

3.1. Institutions holding Embecta Corp

Institutions are holding 98.584% of the shares of Embecta Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc16.37290.004694273355047025.6564
2023-12-31Vanguard Group Inc12.20250.00297026076205090.2928
2023-12-31Millennium Management LLC6.31470.029836359482851268.5091
2023-12-31River Road Asset Management, LLC5.74990.8702331074969727426.68
2023-12-31Yacktman Asset Management Co4.63930.47022671237202960.7656
2023-12-31American Century Companies Inc4.53380.0342610526-1824085-41.1329
2023-12-31State Street Corporation4.37120.00232516911411291.6613
2023-12-31FMR Inc4.12280.00352373840282451.2042
2023-12-31HHG PLC3.03260.01971746137664293.9548
2023-12-31Charles Schwab Investment Management Inc2.23870.0062128899529699729.9393
2023-12-31Geode Capital Management, LLC2.23760.00261288398604744.9249
2023-12-31Goldman Sachs Group Inc2.18170.0021125621021995721.2262
2023-12-31Morgan Stanley - Brokerage Accounts1.69340.001697506628533741.3694
2023-12-31Balyasny Asset Management LLC1.48990.0305857891-631980-42.4184
2023-12-31Bank of New York Mellon Corp1.38210.0031795802131161.6758
2023-12-31Sio Capital Management, LLC1.27833.172373600816771429.5118
2023-12-31Northern Trust Corp1.1550.0023665012181592.8073
2023-09-30Citadel Advisors Llc1.10090.0021633902386120155.8305
2023-12-31Arnhold & S. Bleichroeder Advisers, LLC1.00410.02615781789260019.0701
2023-09-30D. E. Shaw & Co LP0.93180.0084536505-42138-7.2822
Total 78.03324.694544930726+705981+1.6%

3.2. Funds holding Embecta Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29iShares Core S&P Small-Cap ETF6.78070.072390427663000.1616
2023-12-31American Century Small Cap Value Inv3.63950.673320955841855849.7164
2023-12-31American Century U.S. Small Cap Value3.63950.674420955841855849.7164
2024-02-29Vanguard Total Stock Mkt Idx Inv3.09880.0016178426600
2023-12-31Fidelity Low-Priced Stock2.99750.1187172595600
2023-12-31AMG Yacktman I2.77880.3574160000000
2023-12-31Janus Henderson Small Cap Value L2.56691.11871477966625384.4183
2024-02-29Vanguard Small Cap Index2.56660.0151477814137430.9387
2024-02-29iShares Russell 2000 ETF2.43530.03211402218-229-0.0163
2024-02-29Vanguard Small Cap Value Index Inv1.7530.0271100937541760.4154
2024-02-29AMG River Road Small Cap Value N1.52521.232187819011689915.3554
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.48820.01285691067430.7931
2024-02-29iShares S&P Small-Cap 600 Value ETF1.26120.147472617119980.2759
2024-02-29Schwab Fundamental US Small Company ETF1.15270.11826637342300.0347
2023-12-31Fidelity Small Cap Index0.99640.042757372370621.2462
2023-12-31First Eagle US Small Cap Strategy0.93140.60125363118352018.4456
2024-02-29SPDR® Portfolio S&P 600 Sm Cap ETF0.8920.07145135961060.0206
2024-02-01iShares Russell 2000 Value ETF0.84640.07244873606160.1266
2024-02-29First Eagle Small Cap Opportunity I0.83870.3936482888-68233-12.3808
2024-02-29Vanguard Tax-Managed Small Cap Adm0.78640.072845277300
Total 42.97525.854124744695+606637+2.5%

3.3. Insider Transactions

Insiders are holding 0.475% of the shares of Embecta Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-02-12David F MelcherBUY200016.25
2023-09-08David F MelcherBUY623315.77
2023-08-10Devdatt KurdikarBUY500021.81
2023-08-10Jacob ElguiczeBUY462521.66
2023-08-10Jeffrey Z MannBUY470021.67

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Embecta Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.502-3.438+784%-2.394+576%-1.059+311%-1.059+311%
Book Value Per Share---13.768-14.096+2%-11.699-15%-6.408-53%-6.408-53%
Current Ratio--2.2032.119+4%2.333-6%1.632+35%1.632+35%
Debt To Asset Ratio--1.6521.664-1%1.872-12%1.126+47%1.126+47%
Debt To Equity Ratio----0%-0%0.052-100%0.052-100%
Dividend Per Share--0.1490.187-20%0.037+299%0.069+116%0.069+116%
Eps--0.3490.240+45%0.538-35%0.926-62%0.926-62%
Free Cash Flow Per Share---0.274-0.131-52%1.098-125%1.036-126%1.036-126%
Free Cash Flow To Equity Per Share---0.508-0.375-26%1.471-135%0.340-250%0.340-250%
Gross Profit Margin--1.000-0.365+137%1.0000%0.580+72%0.580+72%
Intrinsic Value_10Y_max---89.349--------
Intrinsic Value_10Y_min---72.747--------
Intrinsic Value_1Y_max--2.002--------
Intrinsic Value_1Y_min--1.973--------
Intrinsic Value_3Y_max---2.333--------
Intrinsic Value_3Y_min---2.059--------
Intrinsic Value_5Y_max---16.735--------
Intrinsic Value_5Y_min---14.815--------
Market Cap598820560.000-82%1090973760.0001205106518.250-9%364707064952.883-100%112588360452.656-99%112588360452.656-99%
Net Profit Margin--0.0720.049+47%0.184-61%0.208-65%0.208-65%
Operating Margin--0.1510.160-6%0.333-54%0.312-51%0.312-51%
Operating Ratio--0.8360.8390%0.773+8%0.720+16%0.720+16%
Pb Ratio-0.755+45%-1.375-1.484+8%-436.085+31618%-134.637+9693%-134.637+9693%
Pe Ratio7.455-82%13.56924.761-45%2578.234-99%800.922-98%800.922-98%
Price Per Share10.400-82%18.93020.925-10%28.183-33%15.110+25%15.110+25%
Price To Free Cash Flow Ratio-9.484+45%-17.262-11.872-31%1637.378-101%500.156-103%500.156-103%
Price To Total Gains Ratio15.959-82%29.048-36.877+227%-6.346+122%-21.611+174%-21.611+174%
Quick Ratio--1.5471.408+10%1.606-4%1.055+47%1.055+47%
Return On Assets--0.0170.011+46%0.046-64%0.037-56%0.037-56%
Return On Equity----0%-0%0.026-100%0.026-100%
Total Gains Per Share--0.652-3.252+599%-2.356+462%-0.990+252%-0.990+252%
Usd Book Value---793500000.000-811800000.000+2%-885650000.000+12%-434253846.154-45%-434253846.154-45%
Usd Book Value Change Per Share--0.502-3.438+784%-2.394+576%-1.059+311%-1.059+311%
Usd Book Value Per Share---13.768-14.096+2%-11.699-15%-6.408-53%-6.408-53%
Usd Dividend Per Share--0.1490.187-20%0.037+299%0.069+116%0.069+116%
Usd Eps--0.3490.240+45%0.538-35%0.926-62%0.926-62%
Usd Free Cash Flow---15800000.000-7575000.000-52%77350000.000-120%64015384.615-125%64015384.615-125%
Usd Free Cash Flow Per Share---0.274-0.131-52%1.098-125%1.036-126%1.036-126%
Usd Free Cash Flow To Equity Per Share---0.508-0.375-26%1.471-135%0.340-250%0.340-250%
Usd Market Cap598820560.000-82%1090973760.0001205106518.250-9%364707064952.883-100%112588360452.656-99%112588360452.656-99%
Usd Price Per Share10.400-82%18.93020.925-10%28.183-33%15.110+25%15.110+25%
Usd Profit--20100000.00013825000.000+45%45050000.000-55%57638461.538-65%57638461.538-65%
Usd Revenue--277300000.000280600000.000-1%257250000.000+8%277361538.4620%277361538.4620%
Usd Total Gains Per Share--0.652-3.252+599%-2.356+462%-0.990+252%-0.990+252%
 EOD+2 -6MRQTTM+21 -13YOY+13 -205Y+14 -2210Y+14 -22

4.2. Fundamental Score

Let's check the fundamental score of Embecta Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-157.455
Price to Book Ratio (EOD)Between0-1-0.755
Net Profit Margin (MRQ)Greater than00.072
Operating Margin (MRQ)Greater than00.151
Quick Ratio (MRQ)Greater than11.547
Current Ratio (MRQ)Greater than12.203
Debt to Asset Ratio (MRQ)Less than11.652
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.017
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Embecta Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5031.446
Ma 20Greater thanMa 5011.448
Ma 50Greater thanMa 10012.820
Ma 100Greater thanMa 20015.124
OpenGreater thanClose10.650
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,217,800
Total Liabilities2,011,300
Total Stockholder Equity-793,500
 As reported
Total Liabilities 2,011,300
Total Stockholder Equity+ -793,500
Total Assets = 1,217,800

Assets

Total Assets1,217,800
Total Current Assets719,500
Long-term Assets498,300
Total Current Assets
Cash And Cash Equivalents 298,700
Net Receivables 206,400
Inventory 149,200
Other Current Assets 65,200
Total Current Assets  (as reported)719,500
Total Current Assets  (calculated)719,500
+/-0
Long-term Assets
Property Plant Equipment 301,300
Goodwill 15,500
Intangible Assets 8,800
Long-term Assets Other 172,700
Long-term Assets  (as reported)498,300
Long-term Assets  (calculated)498,300
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities326,600
Long-term Liabilities1,684,700
Total Stockholder Equity-793,500
Total Current Liabilities
Short-term Debt 13,200
Short Long Term Debt 9,500
Accounts payable 42,100
Other Current Liabilities 237,200
Total Current Liabilities  (as reported)326,600
Total Current Liabilities  (calculated)302,000
+/- 24,600
Long-term Liabilities
Long term Debt 1,592,900
Capital Lease Obligations 34,800
Long-term Liabilities Other 60,700
Long-term Liabilities  (as reported)1,684,700
Long-term Liabilities  (calculated)1,688,400
+/- 3,700
Total Stockholder Equity
Common Stock600
Retained Earnings -530,000
Accumulated Other Comprehensive Income -297,500
Other Stockholders Equity 33,400
Total Stockholder Equity (as reported)-793,500
Total Stockholder Equity (calculated)-793,500
+/-0
Other
Capital Stock600
Cash and Short Term Investments 298,700
Common Stock Shares Outstanding 57,632
Current Deferred Revenue34,100
Liabilities and Stockholders Equity 1,217,800
Net Debt 1,338,500
Net Invested Capital 808,900
Net Working Capital 392,900
Property Plant and Equipment Gross 759,100
Short Long Term Debt Total 1,637,200



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-31
> Total Assets 
0
0
0
788,000
739,900
833,500
1,049,800
1,086,400
1,196,900
1,210,000
1,252,100
1,214,400
1,217,800
1,217,8001,214,4001,252,1001,210,0001,196,9001,086,4001,049,800833,500739,900788,000000
   > Total Current Assets 
0
0
0
292,000
258,300
426,500
580,600
664,700
761,700
756,300
787,500
749,100
719,500
719,500749,100787,500756,300761,700664,700580,600426,500258,300292,000000
       Cash And Cash Equivalents 
0
0
0
0
0
264,300
292,300
330,900
385,200
346,400
317,400
326,500
298,700
298,700326,500317,400346,400385,200330,900292,300264,30000000
       Net Receivables 
0
0
0
151,000
118,300
15,200
119,200
133,100
143,300
152,700
190,100
159,100
206,400
206,400159,100190,100152,700143,300133,100119,20015,200118,300151,000000
       Other Current Assets 
0
0
0
23,000
20,900
24,600
248,400
306,000
213,200
99,600
109,700
111,400
65,200
65,200111,400109,70099,600213,200306,000248,40024,60020,90023,000000
   > Long-term Assets 
0
0
0
496,000
481,600
407,000
469,200
421,700
435,200
453,700
464,600
465,300
498,300
498,300465,300464,600453,700435,200421,700469,200407,000481,600496,000000
       Property Plant Equipment 
0
0
0
451,000
436,500
355,700
375,700
301,600
314,300
313,500
308,700
300,200
301,300
301,300300,200308,700313,500314,300301,600375,700355,700436,500451,000000
       Goodwill 
0
0
0
16,000
15,600
15,700
15,700
15,700
15,700
15,700
15,700
15,600
15,500
15,50015,60015,70015,70015,70015,70015,70015,70015,60016,000000
       Intangible Assets 
0
0
0
18,000
18,300
19,000
9,300
8,900
8,600
8,300
9,300
9,100
8,800
8,8009,1009,3008,3008,6008,9009,30019,00018,30018,000000
       Other Assets 
0
0
0
0
11,200
16,600
63,900
89,200
96,600
0
109,900
0
0
00109,900096,60089,20063,90016,60011,2000000
> Total Liabilities 
0
0
0
194,000
189,400
1,801,000
1,897,400
1,977,800
2,033,000
2,032,600
2,061,500
2,036,100
2,011,300
2,011,3002,036,1002,061,5002,032,6002,033,0001,977,8001,897,4001,801,000189,400194,000000
   > Total Current Liabilities 
0
0
0
164,000
159,100
168,900
228,500
301,000
370,300
357,700
385,800
353,500
326,600
326,600353,500385,800357,700370,300301,000228,500168,900159,100164,000000
       Short-term Debt 
0
0
0
0
0
9,500
13,100
13,100
13,100
13,100
13,100
13,100
13,200
13,20013,10013,10013,10013,10013,10013,1009,50000000
       Short Long Term Debt 
0
0
0
0
0
9,500
9,500
9,500
9,500
9,500
9,500
9,500
9,500
9,5009,5009,5009,5009,5009,5009,5009,50000000
       Accounts payable 
0
0
0
54,000
58,100
50,800
64,300
41,400
37,200
52,500
56,100
53,500
42,100
42,10053,50056,10052,50037,20041,40064,30050,80058,10054,000000
       Other Current Liabilities 
0
0
0
110,000
101,000
108,600
114,300
246,500
223,400
292,100
281,200
253,300
237,200
237,200253,300281,200292,100223,400246,500114,300108,600101,000110,000000
   > Long-term Liabilities 
0
0
0
30,000
30,300
1,632,100
1,668,900
1,676,800
1,662,700
1,674,900
1,675,700
1,682,600
1,684,700
1,684,7001,682,6001,675,7001,674,9001,662,7001,676,8001,668,9001,632,10030,30030,000000
       Long term Debt Total 
0
0
0
0
0
1,403,700
1,599,200
1,598,100
1,597,100
1,596,000
1,595,000
0
0
001,595,0001,596,0001,597,1001,598,1001,599,2001,403,70000000
       Other Liabilities 
0
0
0
0
30,300
31,400
32,900
41,800
28,700
0
33,900
0
0
0033,900028,70041,80032,90031,40030,3000000
       Deferred Long Term Liability 
0
0
0
0
0
31,400
36,800
46,100
33,300
46,900
48,900
0
0
0048,90046,90033,30046,10036,80031,40000000
> Total Stockholder Equity
0
0
0
594,000
550,500
-967,500
-847,600
-891,400
-836,100
-822,600
-809,400
-821,700
-793,500
-793,500-821,700-809,400-822,600-836,100-891,400-847,600-967,500550,500594,000000
   Common Stock
0
0
0
865,000
829,800
-681,100
600
600
600
600
600
600
600
600600600600600600600-681,100829,800865,000000
   Retained Earnings Total Equity00-538,500-545,100-550,500-577,100-556,000000000
   Accumulated Other Comprehensive Income -297,500-309,100-294,700-296,200-298,900-324,900-298,000-286,400-279,300-271,000000
   Capital Surplus 
0
0
0
0
0
0
5,800
10,000
12,700
18,100
23,200
0
0
0023,20018,10012,70010,0005,800000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
0
0
0
0
-279,300
-681,100
5,800
10,000
12,700
18,100
23,200
27,900
33,400
33,40027,90023,20018,10012,70010,0005,800-681,100-279,3000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue1,120,800
Cost of Revenue-370,900
Gross Profit749,900749,900
 
Operating Income (+$)
Gross Profit749,900
Operating Expense-525,900
Operating Income221,500224,000
 
Operating Expense (+$)
Research Development85,200
Selling General Administrative341,300
Selling And Marketing Expenses0
Operating Expense525,900426,500
 
Net Interest Income (+$)
Interest Income0
Interest Expense-107,000
Other Finance Cost-0
Net Interest Income-107,000
 
Pretax Income (+$)
Operating Income221,500
Net Interest Income-107,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)105,700232,800
EBIT - interestExpense = 108,200
105,700
177,400
Interest Expense107,000
Earnings Before Interest and Taxes (EBIT)215,200212,700
Earnings Before Interest and Taxes (EBITDA)247,800
 
After tax Income (+$)
Income Before Tax105,700
Tax Provision-35,300
Net Income From Continuing Ops70,40070,400
Net Income70,400
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses896,800
Total Other Income/Expenses Net-11,300107,000
 

Technical Analysis of Embecta
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Embecta. The general trend of Embecta is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Embecta's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Embecta Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 12.32 < 13.37 < 13.60.

The bearish price targets are: 9.925.

Tweet this
Embecta Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Embecta Corp. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Embecta Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Embecta Corp. The current macd is -0.7414439.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Embecta price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Embecta. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Embecta price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Embecta Corp Daily Moving Average Convergence/Divergence (MACD) ChartEmbecta Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Embecta Corp. The current adx is 40.79.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Embecta shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Embecta Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Embecta Corp. The current sar is 10.98.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Embecta Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Embecta Corp. The current rsi is 31.45. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Embecta Corp Daily Relative Strength Index (RSI) ChartEmbecta Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Embecta Corp. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Embecta price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Embecta Corp Daily Stochastic Oscillator ChartEmbecta Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Embecta Corp. The current cci is -65.64630737.

Embecta Corp Daily Commodity Channel Index (CCI) ChartEmbecta Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Embecta Corp. The current cmo is -36.93298651.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Embecta Corp Daily Chande Momentum Oscillator (CMO) ChartEmbecta Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Embecta Corp. The current willr is -84.08710218.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Embecta Corp Daily Williams %R ChartEmbecta Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Embecta Corp.

Embecta Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Embecta Corp. The current atr is 0.47701789.

Embecta Corp Daily Average True Range (ATR) ChartEmbecta Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Embecta Corp. The current obv is -4,863,547.

Embecta Corp Daily On-Balance Volume (OBV) ChartEmbecta Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Embecta Corp. The current mfi is 28.48.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Embecta Corp Daily Money Flow Index (MFI) ChartEmbecta Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Embecta Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Embecta Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Embecta Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5031.446
Ma 20Greater thanMa 5011.448
Ma 50Greater thanMa 10012.820
Ma 100Greater thanMa 20015.124
OpenGreater thanClose10.650
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Embecta with someone you think should read this too:
  • Are you bullish or bearish on Embecta? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Embecta? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Embecta Corp

I send you an email if I find something interesting about Embecta Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Embecta Corp.

Receive notifications about Embecta Corp in your mailbox!